Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparison of Multimorbidity in COVID-19 infected and general population in Portugal

Miguel Froes, Bernardo Neves, Bruno Martins, Mário J. Silva
doi: https://doi.org/10.1101/2020.07.02.20144378
Miguel Froes
1Instituto Superior Técnico Universidade de Lisboa Lisboa, Portugal
Roles: INESC-ID
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: miguel.froes@tecnico.ulisboa.pt
Bernardo Neves
2Dep. de Medicina Interna Hospital da Luz Lisboa, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Martins
3Instituto Superior Técnico Universidade de Lisboa Lisboa, Portugal
Roles: INESC-ID
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mário J. Silva
4Instituto Superior Técnico Universidade de Lisboa Lisboa, Portugal
Roles: INESC-ID
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Understanding COVID-19 and its risk factors in the Portuguese population is critical to the struggle against this infectious disease. To study the impact of multimorbidity in the population with COVID-19 infection, we performed a descriptive analysis of a dataset extracted from all reported confirmed cases of COVID-19 in Portugal until June 30, 2020. We observed a prevalence of multimorbidity in 6.77% of the 36,244 infected patients. These patients showed an increased risk of hospitalization, ICU admission, and mortality with OR 2.22 (CI 95%: 2.13-2.32) for every additional morbidity. Further studies should confirm these findings and special attention should be made on data collection, to ensure proper recording of patient comorbidities.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee: "Comissao de Etica do IST", " http://etica.tecnico.ulisboa.pt/" Study previously authorized by the IST-EC according to waht was made public in: " https://drive.tecnico.ulisboa.pt/download/288548787958179" Ref. n 9/2020 (CE-IST) Date: 20/04/2020

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Figures label revised; and Section 2 updated

Data Availability

This retrospective observational study used data provided by DGS after the required institutional and ethical approvals. The sample population consists of all the Portuguese population with SARS-CoV2 confirmed infection as notified by clinicians by June 30, 2020. A broad range of clinical and demographic variables are present in this dataset. In this study we specifically used age, gender, hospital admission, admission in intensive care unit, mortality and patient's underlying conditions.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 08, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Multimorbidity in COVID-19 infected and general population in Portugal
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparison of Multimorbidity in COVID-19 infected and general population in Portugal
Miguel Froes, Bernardo Neves, Bruno Martins, Mário J. Silva
medRxiv 2020.07.02.20144378; doi: https://doi.org/10.1101/2020.07.02.20144378
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Comparison of Multimorbidity in COVID-19 infected and general population in Portugal
Miguel Froes, Bernardo Neves, Bruno Martins, Mário J. Silva
medRxiv 2020.07.02.20144378; doi: https://doi.org/10.1101/2020.07.02.20144378

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (556)
  • Anesthesia (135)
  • Cardiovascular Medicine (1766)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (313)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (661)
  • Epidemiology (10806)
  • Forensic Medicine (8)
  • Gastroenterology (593)
  • Genetic and Genomic Medicine (2958)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1932)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (632)
  • Infectious Diseases (except HIV/AIDS) (12522)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2803)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1472)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5379)
  • Radiology and Imaging (1015)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (126)